AlphaFold 4 Precisely Cracks 3D Structure of Key Cancer Proteins, Nature Validation Drives Stock Surge, Why 10 Years from Prediction to Drug?
Isomorphic Labs' AlphaFold 4 achieves breakthrough in predicting cancer protein structures with 95% accuracy, published in Nature, triggering biotech stock rally. However, the path from structural prediction to actual drug development still faces a 10-year marathon due to technical and regulatory challenges.